John Carpenter - Shimmick Common Executive Counsel
| SHIM Stock | 3.15 0.18 6.06% |
Executive
John Carpenter is Executive Counsel of Shimmick Common
| Address | 530 Technology Drive, Irvine, CA, United States, 92618 |
| Phone | 833-723-2021 |
| Web | https://www.shimmick.com |
Shimmick Common Management Efficiency
The company has return on total asset (ROA) of (0.1516) % which means that it has lost $0.1516 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.0243) %, meaning that it created substantial loss on money invested by shareholders. Shimmick Common's management efficiency ratios could be used to measure how well Shimmick Common manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of December 2024, Return On Capital Employed is likely to grow to 0.12, while Return On Tangible Assets are likely to drop 0.01. At this time, Shimmick Common's Non Currrent Assets Other are very stable compared to the past year. As of the 30th of December 2024, Total Current Assets is likely to grow to about 273.6 M, while Non Current Assets Total are likely to drop about 165.2 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Drew Badger | Apogee Therapeutics, Common | N/A | |
| Heather Boussios | Mink Therapeutics | N/A | |
| JD Esq | Centessa Pharmaceuticals PLC | N/A | |
| Harris Rotman | Centessa Pharmaceuticals PLC | N/A | |
| Vincent Dequenne | Valneva SE ADR | 57 | |
| Dan Mulreany | Apogee Therapeutics, Common | N/A | |
| Lisa Birringer | BioNTech SE | N/A | |
| Joseph Reilly | Ardelyx | 51 | |
| April Dovholuk | Centessa Pharmaceuticals PLC | N/A | |
| Matthew JD | Apogee Therapeutics, Common | 48 | |
| Jennifer Moore | Where Food Comes | N/A | |
| Michael Bross | Rackspace Technology | N/A | |
| Sara Simpson | Where Food Comes | N/A | |
| Kellie TealGuess | Rackspace Technology | N/A | |
| Sebastian MD | BioNTech SE | N/A | |
| Noel Kurdi | Apogee Therapeutics, Common | N/A | |
| Doug Stanton | Where Food Comes | N/A | |
| Sean Marett | BioNTech SE | 59 | |
| Joseph Crivelli | Rackspace Technology | N/A | |
| Katalin Kariko | BioNTech SE | N/A | |
| Jane Henderson | Apogee Therapeutics, Common | 58 | |
Management Performance
| Return On Equity | -4.02 | ||||
| Return On Asset | -0.15 |
Shimmick Common Leadership Team
Elected by the shareholders, the Shimmick Common's board of directors comprises two types of representatives: Shimmick Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shimmick. The board's role is to monitor Shimmick Common's management team and ensure that shareholders' interests are well served. Shimmick Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shimmick Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mitchell Goldsteen, Executive Chairman | ||
| Steven Richards, Chief Officer | ||
| Devin Nordhagen, Executive Officer | ||
| Andrew PE, President | ||
| Amanda Mobley, Director VP | ||
| John Carpenter, Executive Counsel |
Shimmick Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shimmick Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.02 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.55) % | ||||
| Current Valuation | 137.52 M | ||||
| Shares Outstanding | 33.8 M | ||||
| Shares Owned By Insiders | 91.09 % | ||||
| Shares Owned By Institutions | 7.00 % | ||||
| Number Of Shares Shorted | 228.11 K | ||||
| Price To Book | 94.05 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Shimmick Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Shimmick Stock, please use our How to Invest in Shimmick Common guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Construction & Engineering space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shimmick Common. If investors know Shimmick will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shimmick Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.08) | Revenue Per Share 21.127 | Quarterly Revenue Growth (0.42) | Return On Assets (0.15) | Return On Equity (4.02) |
The market value of Shimmick Common is measured differently than its book value, which is the value of Shimmick that is recorded on the company's balance sheet. Investors also form their own opinion of Shimmick Common's value that differs from its market value or its book value, called intrinsic value, which is Shimmick Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shimmick Common's market value can be influenced by many factors that don't directly affect Shimmick Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shimmick Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shimmick Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shimmick Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.